相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Radioresistance and Transcriptional Reprograming of Invasive Glioblastoma Cells
Zili Tang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2
Tracy J. Berg et al.
CANCER RESEARCH (2021)
Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence
Eliot Fletcher-Sananikone et al.
CANCER RESEARCH (2021)
Diffuse Glioma Heterogeneity and Its Therapeutic Implications
James G. Nicholson et al.
CANCER DISCOVERY (2021)
Protein kinase CI, and SRC signaling define reciprocally related subgroups of glioblastoma with distinct therapeutic vulnerabilities
Rajappa S. Kenchappa et al.
CELL REPORTS (2021)
N-cadherin upregulation mediates adaptive radioresistance in glioblastoma
Satoru Osuka et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
The Impact of Epigenetic Modifications on Adaptive Resistance Evolution in Glioblastoma
Qiong Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma
Hyunkoo Kang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Correlation of the quantitative level of MGMT promoter methylation and overall survival in primary diagnosed glioblastomas using the quantitative MethyQESD method
Charlotte von Rosenstiel et al.
JOURNAL OF CLINICAL PATHOLOGY (2020)
Intratumoral spatial heterogeneity of BTK kinomic activity dictates distinct therapeutic response within a single glioblastoma tumor
Ahmed N. Ibrahim et al.
JOURNAL OF NEUROSURGERY (2020)
Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial
Rudolf M. Huber et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity
Fadi Jacob et al.
CELL (2020)
NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target
Alessandro Gambella et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Oncogenic Role of PVT1 and Therapeutic Implications
Onayemi Titilayo Onagoruwa et al.
FRONTIERS IN ONCOLOGY (2020)
Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression
Darshan S. Chandrashekar et al.
ONCOGENE (2020)
A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma
Nicholas J. Eustace et al.
ONCOGENE (2020)
Exploring the Roles of lncRNAs in GBM Pathophysiology and Their Therapeutic Potential
Christian T. Stackhouse et al.
CELLS (2020)
Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
Joana Carlevaro-Fita et al.
COMMUNICATIONS BIOLOGY (2020)
Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis
Verena Koerber et al.
CANCER CELL (2019)
BEERE: a web server for biomedical entity expansion, ranking and explorations
Zongliang Yue et al.
NUCLEIC ACIDS RESEARCH (2019)
Functional role of long non-coding RNA CASC19/miR-140-5p/CEMIP axis in colorectal cancer progression in vitro
Xiao-Dong Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance
Melissa Dolan et al.
PLOS ONE (2019)
A Novel Assay for Profiling GBM Cancer Model Heterogeneity and Drug Screening
Christian T. Stackhouse et al.
CELLS (2019)
Longitudinal molecular trajectories of diffuse glioma in adults
Floris P. Barthel et al.
NATURE (2019)
SOX11: friend or foe in tumor prevention and carcinogenesis?
Zhi Yang et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer
Wanfeng Zhang et al.
GENE (2018)
Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials
D. Ross Camidge et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma
M. -L. Nairismagi et al.
LEUKEMIA (2018)
Kinase-targeted cancer therapies: progress, challenges and future directions
Khushwant S. Bhullar et al.
MOLECULAR CANCER (2018)
ASSA: Fast identification of statistically significant interactions between long RNAs
Ivan Antonov et al.
JOURNAL OF BIOINFORMATICS AND COMPUTATIONAL BIOLOGY (2018)
Sitravatinib potentiates immune checkpoint blockade in refractory cancer models
Wenting Du et al.
JCI INSIGHT (2018)
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro et al.
NATURE METHODS (2017)
Predictive biomarkers of resistance to hypofractionated radiotherapy in high grade glioma
Julian Biau et al.
RADIATION ONCOLOGY (2017)
Candidate tumor suppressor ZNF154 suppresses invasion and metastasis in NPC by inhibiting the EMT via Wnt/β-catenin signalling
Ying Hu et al.
ONCOTARGET (2017)
Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives
Wojciech Szopa et al.
BIOMED RESEARCH INTERNATIONAL (2017)
DGCA: A comprehensive R package for Differential Gene Correlation Analysis
Andrew T. McKenzie et al.
BMC SYSTEMS BIOLOGY (2016)
PAGER: constructing PAGs and new PAG-PAG relationships for network biology
Zongliang Yue et al.
BIOINFORMATICS (2015)
The Ensembl Regulatory Build
Daniel R. Zerbino et al.
GENOME BIOLOGY (2015)
Radiation promotes malignant phenotypes through SRC in breast cancer cells
Rae-Kwon Kim et al.
CANCER SCIENCE (2015)
Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge
Dominik Sturm et al.
NATURE REVIEWS CANCER (2014)
Rad51 Paralog Complexes BCDX2 and CX3 Act at Different Stages in the BRCA1-BRCA2-Dependent Homologous Recombination Pathway
Jarin Chun et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts
Gaspar J. Kitange et al.
CLINICAL CANCER RESEARCH (2012)
Triplexator: Detecting nucleic acid triple helices in genomic and transcriptomic data
Fabian A. Buske et al.
GENOME RESEARCH (2012)
Kinomic profiling approach identifies Trk as a novel radiation modulator
John S. Jarboe et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Exon array data analysis using Affymetrix power tools and R statistical software
Helen E. Lockstone
BRIEFINGS IN BIOINFORMATICS (2011)
Coordinated action of the Fanconi anemia and ataxia telangiectasia pathways in response to oxidative damage
Pau Castillo et al.
DNA REPAIR (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Amplicons on chromosome 12q13-21 in glioblastoma recurrences
Ulrike Fischer et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
MECHANISMS OF DISEASE Susceptibility Pathways in Fanconi's Anemia and Breast Cancer
Alan D. D'Andrea
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Fanconi Anemia Protein FANCM Is Controlled by FANCD2 and the ATR/ATM Pathways
Alexandra Sobeck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers
Eun Goo Jeong et al.
CLINICAL CANCER RESEARCH (2008)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme
C Giannini et al.
NEURO-ONCOLOGY (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)